Shanghai Pharmaceuticals Holding Co Ltd is a manufacturer, retailer, wholesaler, and distributor of healthcare products. The company discovers, develops, produces, and markets pharmaceutical products for the treatment of diarrhoea, jaundice, fever, iron deficiency anaemia, pancreatitis, coronary heart disease, lupus erythematosus, leprosy, acute myocardial infarction, and other diseases. It offers medicines for diseases and disorders of the cardiovascular system, digestive and metabolic system, neurological system, musculoskeletal system, and respiratory system. The company operates its business through four segments – Production, Distribution, Retail, and Others. The Production segment includes the company’s pharmaceutical business, which carries out the research and development, manufacturing, and sale of pharmaceutical and healthcare products. Its Distribution segment carries out the distribution, warehousing, and pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers. The Retail segment operates a network of retail pharmacy stores.